SB Bioseutica cGMP LYSOZYME

BIOSEUTICA BV has been created in 2008 after the merger of Neova Technologies Inc. and KD-PHARMA GmbH. In 2013 a majority stake of KD-PHARMA GmbH has been sold to a german private equity.

Fordras, a Swiss company, has been serving the pharmaceutical and food industries since 1983. Fordras’ international experience in the sales of active pharmaceutical ingredients and food additives makes it one of the leading companies in the development, manufacturing and marketing of specialty, organic products such as Lysozyme.